01a. Alexion Pharma UK comments on the ECD - eculizumab

01b. aHUS UK Response 1 comments on the ECD - eculizumab

01c. aHUS UK Response 2 comments on the ECD - eculizumab

01d. Kidney Research UK comments on the ECD - eculizumab

01e. aHUS Action comments on the ECD - eculizumab

01f. The Royal College of Paediatrics and Child Health comments on the ECD - eculizumab

01g. The Royal College of Physicians & Renal Association (joint submission) comments on the ECD - eculizumab

01h. NHS England comments on the ECD - eculizumab

01i. Welsh Kidney Patients Association comments on the ECD - eculizumab

02. Comments on ECD from members of the public

03. Comments on ECD received through NICE website

Please be advised that the format of evaluation reports shared on the NICE website has recently changed, for ease of user navigation between individual documents contained in the report.

It is a requirement of the new (PDF portfolio) format that Adobe Reader is used to view the document. Please follow the link at the bottom of this page to download Adobe Reader if required.

If you have any feedback on the new format please contact the Project Manager for this evaluation.